The New York Stock Exchange LLC filed a proposed rule change with the Securities and Exchange Commission on December 3, 2025, seeking to amend Section 802.01C of its Listed Company Manual. This amendment would introduce a stricter threshold for continued listing, allowing immediate suspension and delisting if a security's closing price falls below $0.25 on any trading day. Published in the Federal Register on March 20, 2026, the notice also details Amendment No. 1, filed on January 22, 2026, which clarified aspects of the proposal. The SEC has instituted proceedings to determine whether to approve or disapprove the change, highlighting its potential impact on market integrity and investor protection. This development responds to observed trends in low-priced stocks, aiming to mitigate manipulation risks while providing issuers a transition period until October 1, 2026.
Background on Current Continued Listing Standards
Section 802.01 of the NYSE Listed Company Manual outlines minimum quantitative and qualitative standards for securities to remain listed on the exchange. Under the existing Section 802.01C, a company falls below compliance if the average closing price of its security dips below $1.00 over a consecutive 30 trading-day period, known as the Price Criteria. Once notified, the company has six months to regain compliance by achieving a closing price and average price above $1.00 on the last trading day of any month within that period.
If unsuccessful, the exchange initiates suspension and delisting. However, companies must notify the NYSE of their intent to cure the deficiency, and they are ineligible for certain compliance procedures under Sections 802.02 and 802.03. In practice, the exchange already acts swiftly if a stock trades below $0.10, regardless of the cure period, due to concerns over volatility and manipulation. The proposal builds on this framework, drawing from the exchange's ongoing monitoring of companies nearing noncompliance.
Details of the Proposed Amendment
The core of the NYSE's proposal modifies Section 802.01C to establish a Minimum Trading Price of $0.25. If a security's closing price falls below this level on any trading day, the exchange would immediately suspend trading and commence delisting under Section 804.00 of the Manual. Amendment No. 1 specifies that affected companies would not qualify for the standard cure procedures in Sections 802.01C, 802.02, or 802.03.
Additionally, the amendment clarifies the exchange's broader authority under Section 802.01D to suspend or delist securities experiencing a precipitous decline to an abnormally low level, even if above $0.25, if recovery seems unlikely. This codifies existing practices where the exchange evaluates trading conditions that could make further dealings unwarranted. The proposal includes a delayed effective date of October 1, 2026, to allow issuers time to adjust, such as through reverse stock splits, while maintaining restrictions on excessive splits.
Rationale and Justification
The NYSE justifies the change by noting a recent increase in low-priced stocks on public markets, which it says heightens susceptibility to manipulation and volatility. At prices below $0.25, less capital is needed for manipulative activities, according to the exchange's filing. The proposal cites the exchange's experience that such securities rarely recover meaningfully, supporting immediate action over extended cure periods.
For the precipitous decline provision, the exchange references instances where prices drop sharply to levels from which rebound is improbable. This aligns with Section 6(b)(5) of the Securities Exchange Act of 1934, which requires exchange rules to prevent fraudulent practices and protect investors. The filing emphasizes that all issuers retain appeal rights under Section 804.00, ensuring procedural fairness as per Section 6(b)(7) of the Act.
No comment letters were received by the SEC as of the Federal Register publication, but the institution of proceedings invites public input on consistency with these statutory requirements.
Potential Implications and Perspectives
Short-term effects could include accelerated delistings for companies with volatile, low-priced shares, potentially shifting them to over-the-counter markets with less oversight. This might enhance NYSE market quality by reducing manipulation risks, benefiting investors seeking stable trading environments. However, issuers argue that stricter rules could limit access to capital markets, especially for smaller firms facing temporary price dips.
Long-term, the change might encourage companies to maintain higher share prices through proactive measures like reverse splits, fostering greater market discipline. From a regulatory perspective, approval could set precedents for other exchanges, as seen in prior Nasdaq reforms addressing low-bid prices and excessive splits. Critics might view it as overly punitive, potentially discriminating against certain issuers, while supporters see it as essential for public interest protection. The SEC's proceedings will weigh these views against evidence of manipulation trends.
In summary, the NYSE's proposal seeks to strengthen listing standards amid evolving market dynamics. Key takeaways include the new $0.25 threshold for immediate action and clarified authority for low-price declines. Looking ahead, potential next steps involve the SEC's decision by March 17, 2026, or extensions, with possible adjustments based on comments. Ongoing debates may center on balancing investor protection with fair access to exchange listing, influencing future policy on market integrity. Challenges include monitoring implementation effects and addressing any unintended impacts on smaller issuers.
